Brookstone Capital Management Sells 1,673 Shares of Lam Research Corporation $LRCX

Key Points

• Brookstone Capital Management decreased its holdings in Lam Research Corporation by 9.5%, selling 1,673 shares, bringing their total to 15,946 shares valued at approximately $1.55 million.
• A significant number of institutional investors have increased their stakes in Lam Research, with Boston Partners raising its holdings by an extraordinary 9,978.3% in the first quarter.
• Lam Research recently reported earnings per share of $1.26 for the quarter, surpassing estimates, and announced an increase in its quarterly dividend from $0.23 to $0.26.

Brookstone Capital Management lessened its position in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 9.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 15,946 shares of the semiconductor company's stock after selling 1,673 shares during the period. Brookstone Capital Management's holdings in Lam Research were worth $1,552,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of LRCX. Vanguard Group Inc. increased its holdings in shares of Lam Research by 6.9% in the 1st quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company's stock worth $9,389,358,000 after buying an additional 8,364,375 shares during the last quarter. Nuveen LLC bought a new position in shares of Lam Research in the 1st quarter worth $604,344,000. Price T Rowe Associates Inc. MD increased its holdings in shares of Lam Research by 99.7% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,739,221 shares of the semiconductor company's stock worth $417,242,000 after buying an additional 2,864,863 shares during the last quarter. Nordea Investment Management AB increased its holdings in shares of Lam Research by 34.1% in the 2nd quarter. Nordea Investment Management AB now owns 10,594,574 shares of the semiconductor company's stock worth $1,029,210,000 after buying an additional 2,692,189 shares during the last quarter. Finally, Boston Partners increased its holdings in shares of Lam Research by 9,978.3% in the 1st quarter. Boston Partners now owns 2,350,362 shares of the semiconductor company's stock worth $170,787,000 after buying an additional 2,327,041 shares during the last quarter. Institutional investors own 84.61% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on LRCX. B. Riley increased their price target on shares of Lam Research from $160.00 to $175.00 and gave the stock a "buy" rating in a report on Monday, October 20th. JPMorgan Chase & Co. increased their price target on shares of Lam Research from $113.00 to $165.00 and gave the stock an "overweight" rating in a report on Thursday. Berenberg Bank increased their price target on shares of Lam Research from $122.00 to $165.00 and gave the stock a "buy" rating in a report on Thursday. UBS Group set a $165.00 price objective on shares of Lam Research and gave the company a "buy" rating in a research note on Thursday. Finally, Cowen reaffirmed a "buy" rating on shares of Lam Research in a research note on Thursday. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $147.21.

Lam Research Trading Up 2.8%

Shares of LRCX opened at $151.68 on Friday. The stock has a market capitalization of $191.27 billion, a P/E ratio of 33.41, a PEG ratio of 1.76 and a beta of 1.84. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. The firm has a fifty day simple moving average of $123.23 and a two-hundred day simple moving average of $99.60. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $153.70.

Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.04. The business had revenue of $5.32 billion during the quarter, compared to analysts' expectations of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm's revenue for the quarter was up 27.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, research analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th were given a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 24th. This is an increase from Lam Research's previous quarterly dividend of $0.23. Lam Research's dividend payout ratio is currently 22.91%.

Insiders Place Their Bets

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction on Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the sale, the senior vice president owned 251,047 shares of the company's stock, valued at $34,870,428.30. This represents a 17.21% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.31% of the stock is owned by insiders.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.